Navigation Links
Aflac Reaches $40 Million Milestone in Donations to the Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta
Date:3/19/2008

Contributions Help Fund Ongoing Research, Facilities and Family Support

Services

ATLANTA, March 19 /PRNewswire/ -- In its ongoing support of the Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta, Aflac announced that it has reached more than $40 million in contributions to the Center, making it the largest corporate supporter of Children's Healthcare of Atlanta.

"With financial resources provided by Aflac, we have been able to recruit national leaders in the fields of pediatric cancer, sickle cell disease and experimental therapy and have also established a thriving program for cancer survivors," said William G. Woods, M.D., director for the Aflac Cancer Center. "These leaders are conducting important lab and clinical research and helping to bring innovative treatments to patients at the bedside - not just in Georgia, but nationwide."

Thousands of Aflac field force members across the country and the Aflac Foundation together have funded four endowed chairs at the Aflac Cancer Center, each of which provides critical funding in perpetuity for key positions at the Center. At Children's Healthcare of Atlanta, receiving a chair signifies a monetary endowment for a specific program directed by a physician or researcher. To date, Aflac has funded the following chairs:

-- Dr. William G. Woods - The Daniel P. Amos Children's Chair for the

Aflac Cancer Center and Blood Disorders Service

-- Dr. Donald Durden - The Aflac Field Force Cancer Experimental Therapy

Chair

-- Dr. Lillian R. Meacham - The Kathelen V. Amos Children's Chair for

Cancer Survivorship

-- Dr. Peter Lane - The Aflac Field Force Children's Chair for Sickle Cell

Disease

Over the years, Aflac's contributions have also been used to fund other critical needs, including new inpatient and outpatient facilities, a new state-of-the-art pediatric research building, and endowments for the Family Support Team and Fellowship Program.

In addition to the company's donations, both Aflac employees and field force members support patients and their families by volunteering personal time to play bingo, to take them to Aflac-sponsored events, and to attend the annual Braves Baseball Night with them in Atlanta.

"We became involved with the Aflac Cancer Center and Blood Disorders Service at Children's Healthcare of Atlanta more than 13 years ago to help discover treatments and cures for pediatric cancer and blood disorders," stated Daniel Amos, chairman and chief executive officer of Aflac. "Today, it is recognized as one of the leading pediatric cancer, hematology, and blood and marrow transplantation programs in the country, treating more than 325 new cancer patients each year and following more than 2,000 patients with sickle cell disease, hemophilia and other blood disorders."

The Aflac Cancer Center and Blood Disorders Service provides advanced diagnostic and clinical care, as well as innovative treatment and research options to children, adolescents and young adults.

About Aflac

For more than 50 years, Aflac products have given policyholders the opportunity to direct cash where it is needed most when a life-interrupting medical event causes financial challenges. Aflac is the number one provider of guaranteed-renewable insurance in the United States and the number one insurance company in terms of individual insurance policies in force in Japan. Our insurance products provide protection to more than 40 million people worldwide. Aflac has been included in Fortune magazine's listing of America's Most Admired Companies for seven years and in Fortune magazine's list of the 100 Best Companies to Work For in America for ten consecutive years. Aflac has also been recognized three times by both Fortune magazine's listing of the Top 50 Employers for Minorities and Working Mother magazine's listing of the 100 Best Companies for Working Mothers. Aflac Incorporated is a Fortune 500 company listed on the New York Stock Exchange under the symbol AFL. To find out more about Aflac, visit aflac.com.

About Children's Healthcare of Atlanta

Children's Healthcare of Atlanta, one of the leading pediatric healthcare systems in the country, is a not-for-profit organization that benefits from the generous philanthropic and volunteer support of our community. Operating three hospitals with more than half a million patient visits annually, Children's is recognized for excellence in cancer, cardiac, neonatal, orthopaedic and transplant services, as well as many other pediatric specialties. To learn more about Children's Healthcare of Atlanta, visit our Web site at http://www.choa.org or call 404-250-KIDS.

About the Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta

The Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta is a national leader among childhood cancer, hematology, and blood and marrow transplant programs, serving infants to young adults. Recognized as one of the top five pediatric cancer centers in the country by Child magazine, the Aflac Cancer Center treats more than 325 new cancer patients each year and follows more than 2,000 patients with sickle cell disease, hemophilia and other blood disorders. The Aflac Cancer Center is one of many programs at Children's committed to enhancing the lives of children through excellence in patient care, research and education. Children's, one of the top three pediatric healthcare systems in the country, is a not-for-profit organization that benefits from the generous philanthropic and volunteer support of our community. Visit http://www.aflaccancercenter.org or call 404-250-KIDS for more information.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080319/CLW006-a )

(Photo: http://www.newscom.com/cgi-bin/prnh/20080319/CLW006-b )

(Logo: http://www.newscom.com/cgi-bin/prnh/20041202/CLTH019LOGO )

Media Contacts: Analyst and Investment Contact:

Laura Kane Kenneth S. Janke Jr.

Aflac Incorporated Aflac Incorporated

706.596.3493 800.235.2667, Option 3; Fax: 706.324.6330

lkane@aflac.com kjanke@aflac.com

Brant Rawls

Children's Healthcare of Atlanta

404.785.7577

brant.rawls@choa.org


'/>"/>
SOURCE Aflac
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Aflac Incorporated to Present at the Raymond James 29th Annual Institutional Investors Conference
2. Training Magazine Applauds Aflacs Employee Learning Programs
3. Aflac Incorporated Announces Fourth Quarter Results
4. Aflac Incorporated to Accelerate Share Repurchase in 2008; Authorizes Additional Share Repurchase and Increases Quarterly Cash Dividend 17.1%
5. Aflac to Sponsor Iron Girl
6. Aflac Incorporated to Present at the Goldman Sachs Financial Services CEO Conference 2007
7. Aflac Japan To Offer Cancer Insurance Product Through Japan Post
8. Aflac Honors Hispanic Entrepreneurs Making a Difference in Texas
9. Aflac Incorporated Announces Third Quarter Results, Declares Fourth Quarter Cash Dividend
10. Aflac Incorporated to Release Third Quarter Results On October 23, 2007
11. Aflac Announces Resignation of U.S. Marketing Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... whiteboard display solutions, proudly announced today that a new solution for Emergency Departments ... fit in the tight space in Emergency Department examination rooms, and with a ...
(Date:12/8/2016)... Cambridge, MA (PRWEB) , ... December 08, 2016 ... ... the Workers Compensation Research Institute (WCRI) officially opened registration today for its ... Place Hotel in Boston, MA . , The theme of the conference is ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s leading digital ... aligned with Upstage Lung Cancer in efforts to combat lung cancer, announced CURE Media ... Jr said, “CURE Media Group is honored to team up with Upstage Lung Cancer ...
(Date:12/8/2016)... (PRWEB) , ... December 08, ... ... Presence Suite 10.2 version gives development continuity to its innovative Unified Instance ... channels management capacity. In addition, this new version optimizes the unattended auto-dialing ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are encouraged ... in mind, SIGVARIS has created a new line of anti-embolism stockings to help ... provide the benefits of graduated compression when transitioning from recovery to early rehabilitation. ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 8, 2016 KEY FINDINGS ... of the market in 2016 and is expected to ... attributed to a large number of surgical procedures that ... largest share in the patient temperature management market.) Patient ... reducing loss of blood during surgeries, lowering the risks ...
(Date:12/8/2016)... Research and Markets has announced the addition ... Adhesion Type, Application, Usability - Forecast to 2025" report to ... , , ... poised to grow at a CAGR of around 3.2% from 2015 ... witnessing include advancements in extracellular microelectrode arrays and intracellular microelectrodes, research ...
(Date:12/8/2016)... 2016  Valeant Pharmaceuticals International, Inc. (NYSE: ... announced positive results from a Phase 3, multicenter ... safety and efficacy of IDP-118 (halobetasol propionate and ... Within the Phase 3 study ... psoriasis, IDP-118 showed statistical significance to vehicle with ...
Breaking Medicine Technology: